DnB Asset Management AS
- SEC CIK
- 0001456670
- Latest filing
- Aug 11, 2026
FDMT holding history
4D Molecular Therapeutics, Inc. in every 13F filed by DnB Asset Management AS, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FDMT overviewAll 13F holders of FDMTFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −16,123−100.0% | Sold out | Holders |
| Q4 2025 | 16,123 | $120.9K | <0.1% | −5,516−25.5% | Reduced | Holders |
| Q3 2025 | 21,639 | $188.0K | <0.1% | −6,115−22.0% | Reduced | Holders |
| Q2 2025 | 27,754 | $103.0K | <0.1% | −102−0.4% | Reduced | Holders |
| Q1 2025 | 27,856 | $90.0K | <0.1% | +11,558+70.9% | Added | Holders |
| Q4 2024 | 16,298 | $90.8K | <0.1% | −9,390−36.6% | Reduced | Holders |
| Q3 2024 | 25,688 | $277.7K | <0.1% | +25,688 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −7,363−100.0% | Sold out | Holders |
| Q1 2024 | 7,363 | $234.4K | <0.1% | +7,363 | New | Holders |